Ads attract fewer warning letters

Warning and untitled letters on broadcast and print DTC ads have plummeted since PhRMA's adoption of its Guiding Principles on DTC in August 2005.

In 2004, the FDA's Division of Drug Marketing, Advertising and Communications issued 13 warning and untitled letters on DTC ads. From January to August of 2005, the agency issued 17 warning and untitled letters on DTC ads. Since then, it has issued two—neither of which concerns broadcast or print, the media covered by PhRMA's voluntary code. “It reflects a significant change in attitude at DDMAC,” said John Kamp, executive director of the Coalition for Healthcare Communications.  

You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.